ABBV · All filings · Read this filing
What changed 10-Q
Item 4. Controls and Procedures
2023-11-06 compared with 2023-08-07 · 1 added, 1 removed, 22 unchanged (8% of the section changed)
7 unchanged sentences
Changes in internal control over financial reporting.
−Removed: There were no changes in AbbVie's internal control over financial reporting (as defined in Rule 13a-15(f) under the Securities Exchange Act of 1934) that have materially affected, or are reasonably likely to materially affect, AbbVie's internal control over financial reporting during the quarter ended June 30, 2023.
+Added: There were no changes in AbbVie's internal control over financial reporting (as defined in Rule 13a-15(f) under the Securities Exchange Act of 1934) that have materially affected, or are reasonably likely to materially affect, AbbVie's internal control over financial reporting during the quarter ended September 30, 2023.
Inherent Limitations on Effectiveness of Controls.
13 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.